{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:50:21Z","timestamp":1785894621184,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016037","name":"Fondation Gustave Roussy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejca.2026.116864","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:43:10Z","timestamp":1780674190000},"page":"116864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytokines released by human tumors are independent from cancer histotype"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-346X","authenticated-orcid":false,"given":"Maria","family":"Kuksin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3264-6298","authenticated-orcid":false,"given":"Severine","family":"Mouraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bredel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Radulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chifaou","family":"Mohamed-Djalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Thomas","family":"de Montpr\u00e9ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie E.","family":"Bigorgne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-4821","authenticated-orcid":false,"given":"Mathieu","family":"Rouanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Marabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejca.2026.116864_bib1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ejca.2026.116864_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"issue":"9","key":"10.1016\/j.ejca.2026.116864_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1586\/era.09.88","article-title":"Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses","volume":"9","author":"de Souza","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"issue":"11","key":"10.1016\/j.ejca.2026.116864_bib4","doi-asserted-by":"crossref","first-page":"13060","DOI":"10.18632\/oncotarget.7421","article-title":"Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.ejca.2026.116864_bib5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2016.4059","article-title":"Association of pembrolizumab with tumor response and survival among patients with advanced melanoma","volume":"315","author":"Ribas","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ejca.2026.116864_bib6","first-page":"6457","article-title":"Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma","volume":"15","author":"Imai","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2026.116864_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical Outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejca.2026.116864_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fonc.2018.00390","article-title":"Quantitative analyses of the tumor microenvironment composition and orientation in the era of precision medicine","volume":"8","author":"Petitprez","year":"2018","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116864_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/mutage\/geu073","article-title":"Paradigm shift in oncology: targeting the immune system rather than cancer cells","volume":"30","author":"Shekarian","year":"2015","journal-title":"Mutagenesis"},{"issue":"57","key":"10.1016\/j.ejca.2026.116864_bib10","doi-asserted-by":"crossref","first-page":"97671","DOI":"10.18632\/oncotarget.18311","article-title":"Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ejca.2026.116864_bib11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/eji.201242529","article-title":"The soluble isoform of CTLA-4 as a regulator of T-cell responses","volume":"43","author":"Ward","year":"2013","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116864_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/cr.2015.3","article-title":"Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25","volume":"25","author":"Hannani","year":"2015","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.ejca.2026.116864_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000842","article-title":"Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition","volume":"8","author":"Laino","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2026.116864_bib14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-020-0856-x","article-title":"Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors","volume":"26","author":"Schalper","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2026.116864_bib15","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1038\/ncomms4987","article-title":"Combinatorial flexibility of cytokine function during human T helper cell differentiation","volume":"5","author":"Touzot","year":"2014","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ejca.2026.116864_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/2326-6066.CIR-16-0060","article-title":"Response to programmed cell death-1 blockade in a murine melanoma syngeneic model requires costimulation, CD4, and CD8 T cells","volume":"4","author":"Homet Moreno","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ejca.2026.116864_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fimmu.2018.00776","article-title":"SV-BR-1-GM, a clinically effective GM-CSF-secreting breast cancer cell line, expresses an immune signature and directly activates CD4+ T lymphocytes","volume":"9","author":"Lacher","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116864_bib18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ijc.2910550118","article-title":"Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression","volume":"55","author":"Gastl","year":"1993","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116864_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CMR.0b013e32834d2506","article-title":"IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells","volume":"22","author":"Jen","year":"2012","journal-title":"Melanoma Res"},{"issue":"6","key":"10.1016\/j.ejca.2026.116864_bib20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ejca.2026.116864_bib21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/10428194.2012.726721","article-title":"Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma","volume":"54","author":"Hassuneh","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2026.116864_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fimmu.2020.01273","article-title":"Role of MIF cytokine\/CD74 receptor pathway in protecting against injury and promoting repair","volume":"11","author":"Farr","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ejca.2026.116864_bib23","article-title":"Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link","volume":"103","author":"H","year":"2010","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"10","key":"10.1016\/j.ejca.2026.116864_bib24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.cdd.4401653","article-title":"MIF loss impairs Myc-induced lymphomagenesis","volume":"12","author":"Talos","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ejca.2026.116864_bib25","unstructured":"\u201cFDA.\u201d [Online]. Available: \u3008https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=255807\u3009. Search orphan drug designations and approvals."},{"key":"10.1016\/j.ejca.2026.116864_bib26","unstructured":"Loux, \u201cNK cells as recipients of cytokine signals | Semantic Scholar.\u201d Accessed: May 30, 2026. [Online]. Available: \u3008https:\/\/www.semanticscholar.org\/paper\/NK-cells-as-recipients-of-cytokine-signals-Loux-Lotze\/59631245026d691e64b3fd9f0839352f342863c8\u3009."},{"issue":"2","key":"10.1016\/j.ejca.2026.116864_bib27","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/cancers6021098","article-title":"CCL21 cancer immunotherapy","volume":"6","author":"Lin","year":"2014","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.ejca.2026.116864_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","article-title":"Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling","volume":"11","author":"Shields","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2026.116864_bib29","series-title":"The cytokines of the immune system","first-page":"143","author":"Dembic","year":"2015"},{"issue":"1","key":"10.1016\/j.ejca.2026.116864_bib30","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-025-57603-1","article-title":"Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice","volume":"16","author":"Wen","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116864_bib31","unstructured":"\u201cNeutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity | Cell Death & Disease.\u201d Accessed: May 30, 2026. [Online]. Available: \u3008https:\/\/www.nature.com\/articles\/s41419-023-06381-z\u3009."},{"issue":"1","key":"10.1016\/j.ejca.2026.116864_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2026.116864_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejca.2022.08.034","article-title":"High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy","volume":"177","author":"Dercle","year":"2022","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2026.116864_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1369\/0022155418824274","article-title":"The diagnostic value of chemokine\/chemokine receptor pairs in hepatocellular carcinoma and colorectal liver metastasis","volume":"67","author":"Jiao","year":"2019","journal-title":"J Histochem Cytochem J Histochem Soc"},{"issue":"7","key":"10.1016\/j.ejca.2026.116864_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/abbs\/gmt049","article-title":"Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages","volume":"45","author":"Li","year":"2013","journal-title":"Acta Biochim Biophys Sin"},{"issue":"4","key":"10.1016\/j.ejca.2026.116864_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/cmi.2010.5","article-title":"Th17 cells and their associated cytokines in liver diseases","volume":"7","author":"Lafdil","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ejca.2026.116864_bib37","unstructured":"\u201cProinflammatory cytokines induce liver and activation-regulated chemokine\/macrophage inflammatory protein-3alpha\/CCL20 in mucosal epithelial cells through NF-kappaB [correction of NK-kappaB] - PubMed.\u201d Accessed: May 30, 2026. [Online]. Available: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/11581170\/\u3009."},{"issue":"8","key":"10.1016\/j.ejca.2026.116864_bib38","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/embor.2010.93","article-title":"Regulation of interleukin-1\u03b2 by interferon-\u03b3 is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production","volume":"11","author":"Masters","year":"2010","journal-title":"EMBO Rep"},{"issue":"487","key":"10.1016\/j.ejca.2026.116864_bib39","doi-asserted-by":"crossref","first-page":"eaau3259","DOI":"10.1126\/scitranslmed.aau3259","article-title":"Targeted antibody and cytokine cancer immunotherapies through collagen affinity","volume":"11","author":"Ishihara","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejca.2026.116864_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fonc.2018.00367","article-title":"The tumor vascular endothelium as decision maker in cancer therapy","volume":"8","author":"Klein","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2026.116864_bib41","unstructured":"\u201cThe tumorigenic and angiogenic effects of MGSA\/GRO proteins in melanoma - PMC.\u201d Accessed: May 30, 2026. [Online]. Available: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2669312\/ ."},{"issue":"1","key":"10.1016\/j.ejca.2026.116864_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5","article-title":"Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity\/growth-regulated cytokine beta and gamma proteins","volume":"73","author":"Owen","year":"1997","journal-title":"Int J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926006453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926006453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:20:57Z","timestamp":1785892857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926006453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S0959804926006453"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116864","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokines released by human tumors are independent from cancer histotype","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116864"}}